Jpmorgan Chase & Co »

Q32 Bio shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Q32 Bio shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $868 51 17.04

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
Vivo Capital
Arch Venture Corp
Temasek Holdings
5AM Venture Management
ADAR1 Capital Management
Platinum Investment Mangement
Vanguard Group
Exome Asset Management
BlackRock
Affinity Asset Advisors
Ensign Peak Advisors
BML Capital Management

View all funds holding Q32 Bio